54
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model

, , , , , , & show all
Pages 4691-4701 | Published online: 18 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Saideh Fakharzadeh, Hassan Argani, Simin Dadashzadeh, Somayeh Kalanaky, Peyman Mohammadi Torbati, Mohammad Hassan Nazaran & Abbas Basiri. (2020) BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease. Diabetes, Metabolic Syndrome and Obesity 13, pages 1179-1188.
Read now

Articles from other publishers (2)

Maria Rosaria Ruggiero, Simona Baroni, Valeria Bitonto, Roberto Ruiu, Smeralda Rapisarda, Silvio Aime & Simonetta Geninatti Crich. (2021) Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model. Frontiers in Oncology 11.
Crossref
Maryam Hafizi, Somayeh Kalanaky, Hassan Moaiery, Maryam Khayamzadeh, Sajad Noorian, Vahid Kaveh, Hossein Foudazi, Behrooz Gharib, Arash Jenabian, Mohsen Razavi, Saeid Salimi, Saideh Fakharzadeh, Afshin Zarghi, Mohammad Hassan Nazaran & Mohammad Esmaeil Akbari. (2019) An Investigation on the Effect of BCc1 Nanomedicine on Gastric Cancer Patients Using EORTC QLQ-STO30 Questionnaire. International Journal of Cancer Management 12:11.
Crossref